This increase of more than 30% of November 1 is not obtained as a result of news concerning Inventiva, caution, therefore, following the speculators who can in the short term vary the action.
In the long run, I think it's a big possibility if the products work and the tests succeed one after the other.
Also, the announcement of an investment fund of a "Call Option" to 12€ before February 2020 is double-edged, a sharp increase is expected and inevitable, a sharp fall if bad news. For me, I bet on a return to 8€ at the end of the year (the same share price as during the introduction) and the passage above 12€ in the first semester of 2020 after the announcement of results (NASH). If bad results, re-fall to very low levels or even abandonment of funds (which own about 20% of the capital), caution ...
Current position:
IVA
To watch closely ...
In the long run, I think it's a big possibility if the products work and the tests succeed one after the other.
Also, the announcement of an investment fund of a "Call Option" to 12€ before February 2020 is double-edged, a sharp increase is expected and inevitable, a sharp fall if bad news. For me, I bet on a return to 8€ at the end of the year (the same share price as during the introduction) and the passage above 12€ in the first semester of 2020 after the announcement of results (NASH). If bad results, re-fall to very low levels or even abandonment of funds (which own about 20% of the capital), caution ...
Current position:
To watch closely ...
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
